RIGL
RIGL
US7665597024
Rigel Pharmaceuticals, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
908.08M EUR
729.74M EUR
499.74M EUR
784.26M EUR
Enterprise Value
854.7M EUR
708.88M EUR
521.05M EUR
796.98M EUR
Valuation Multiples
Trailing P/E
2.91x
2.27x
1.37x
2.21x
Forward P/E
9.94x
--
--
--
Price to Sales
3.28x
2.64x
1.67x
3.25x
Price to Book
2.15x
1.72x
1.25x
2x
EV/Revenue
3.09x
2.56x
1.74x
3.31x
EV/EBITDA
9.53x
7.54x
3.97x
6.78x
Price to FCF (P/FCF)
--
80.71x
6.3x
10.25x
EV/FCF
--
78.4x
6.57x
10.41x
FCF Yield
-3.5%
1.24%
15.86%
9.76%
ende